Your browser doesn't support javascript.
loading
Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents.
González-Hernández, Elena; Aparicio, Rubén; Garayoa, Mercedes; Montero, M José; Sevilla, M Ángeles; Pérez-Melero, Concepción.
Afiliação
  • González-Hernández E; Pharmaceutical Sciences Department , School of Pharmacy , University of Salamanca , Campus Miguel de Unamuno , 37007 Salamanca , Spain . Email: conchapm@usal.es.
  • Aparicio R; Physiology and Pharmacology Department , School of Pharmacy , University of Salamanca , Campus Miguel de Unamuno , 37007 Salamanca , Spain . Email: masevilla@usal.es.
  • Garayoa M; Institute of Biomedical Research of Salamanca (IBSAL) , University Hospital of Salamanca , Paseo de San Vicente, 58-182 , 37007 Salamanca , Spain.
  • Montero MJ; Institute of Biomedical Research of Salamanca (IBSAL) , University Hospital of Salamanca , Paseo de San Vicente, 58-182 , 37007 Salamanca , Spain.
  • Sevilla MÁ; Cancer Research Center , University of Salamanca-CSIC , Campus Miguel de Unamuno , 37007 Salamanca , Spain.
  • Pérez-Melero C; Physiology and Pharmacology Department , School of Pharmacy , University of Salamanca , Campus Miguel de Unamuno , 37007 Salamanca , Spain . Email: masevilla@usal.es.
Medchemcomm ; 10(9): 1589-1598, 2019 Sep 01.
Article em En | MEDLINE | ID: mdl-31673316
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article